Lantheus Holdings, Inc. (LNTH) — Business segments and KPIs
Revenue by business segment and geography for Lantheus Holdings, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 1.51B | 33.4% |
| PYLARIFY | 989.12M | 21.9% |
| Radiopharmaceutical Oncology | 989.12M | 21.9% |
| Total Precision Diagnostics | 493.11M | 10.9% |
| DEFINITY | 330.25M | 7.3% |
| Techne Lite | 86.80M | 1.9% |
| Strategic Partnerships And Other | 59.38M | 1.3% |
| License and Royalty Revenues | 34.04M | 0.8% |
| Other Precision Diagnostics | 24.62M | 0.5% |
| Revenue by region | ||
| UNITED STATES | 1.46B | 94.6% |
| Non-US | 82.73M | 5.4% |